Submitted by Anonymous (not verified) on 29 September 2023 - 13:30
Human medicines European public assessment report (EPAR): Adakveo, crizanlizumab, Anemia, Sickle Cell, Date of authorisation: 28/10/2020, Revision: 6, Status: Withdrawn
Source: